SEC Filing Details

Document Details

Form
Filing Date
Nov 7, 2024
Document Date
Sep 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.